Reply to M. Roschewski et al
- PMID: 24419132
- DOI: 10.1200/JCO.2013.53.0980
Reply to M. Roschewski et al
Comment on
- 
  
  Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.J Clin Oncol. 2013 Jul 10;31(20):2540-7. doi: 10.1200/JCO.2012.46.2119. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733781 Clinical Trial.
- 
  
  Minimal residual disease: what are the minimum requirements?J Clin Oncol. 2014 Feb 10;32(5):475-6. doi: 10.1200/JCO.2013.52.1955. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419126 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        